Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim long-term extension in pediatric ITP
NCT01071954Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 2009
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of romiplostim in immune thrombocytopenia (ITP), sponsored by Amgen. Started Dec 2009; status: completed.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01071954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071954.